This randomized controlled clinical trial was conducted in 2017 on 64 adolescents with asthma who referred to the clinic and the Pediatric Ward of Valiasr (PBUH) Hospital, Birjand, Iran. The sample size was calculated based on the results of a former study (
8) and with a µ
1 of 19.7, a µ
2 of 14.2, an S
1 of 3.6, an S
2 of 5.6, a power of 0.90, and a confidence level of 95%. The sample size calculation (
Equation 1) showed that 29 participants were needed for each group. The sample size was increased to 32 considering an attrition rate of 10%.
Equation 1. Sample size calculation.

A convenience sampling was used to recruit eligible adolescents to the study. The eligibility criteria were an age of 10 - 15, asthma diagnosis by a specialist at least one year before the study, willingness for participation in the study, parental consent for participation, basic literacy skills, use of at least one inhaled asthma medication, and no mental disorders. The exclusion criteria included more than one absence from MI sessions and withdrawal from the study due to events such as accident or death. At the first face-to-face contact with participants and their parents, we informed them about the study and obtained parents’ consent for participation. For random allocation of participants to either of the study groups, each of them was provided with a card labeled A (i.e. control group) and a card labeled B (i.e. intervention group) and was asked to randomly select one card. The label on the card determined the group allocation of the intended participant.
Two questionnaires were used for data collection. The first was a demographic questionnaire with items on age, gender, education level, family income, father’s and mother’s employment status, and place of residence. The second was the Asthma Control Questionnaire with seven items on nighttime awakening, symptom severity upon awakening, activity limitation, shortness of breath, wheezing, number of sprayed puffs, and forced expiratory volume in the past week. Item scoring was done using a seven-point scale from zero (“no symptom or limitation”) to six (“severe symptom or impairment”). The total score of the questionnaire ranged from zero (good asthma control) to 42 (poor asthma control). A former study in Iran reported a Cronbach’s alpha of 0.80 for the Persian version of the questionnaire (
18).
Before the intervention, all participants filled out the study questionnaires. Then, participants in the intervention group were divided into two eleven-person and one ten-person subgroups and then, each subgroup was provided with MI in five 60 - 80-minute weekly sessions. The MI sessions were held based on the approach recommended by Miller and Rollnick (
19). Each participant was required to attend each MI session with either of his/her parents. In the first session, the participants and the interviewer (i.e. the first author) got familiar with each other and group norms and regulations were explained. Then, group members were evaluated respecting their latitude, independence, commitment, confidence, and factors affecting their behaviors. The second session was on the assessment of participants’ feelings about their asthma-related behaviors. Accordingly, a list of positive and negative feelings was provided to each participant and he/she was asked to identify his/her feelings and explain them for other group members. In the third session, brainstorming was used to assess the short- and long-term advantages and disadvantages of behaviors. The positive and negative aspects of each behavior were written in a table and behavior modification strategies were described and exercised. In the fourth session, participants’ values were identified and prioritized, value-behavior gaps were identified, and strategies for filling the gaps were exercised. Finally, in the fifth session, tempting situations were identified and the content of previous sessions was reviewed. On the other hand, participants in the control group received no specific intervention. The posttest was performed for all participants one week and three months after the final MI session.
Study data were analyzed via the SPSS software (V. 19.0). First, the groups were compared concerning participants’ demographic characteristics through the chi-square test. Then, the Kolmogorov-Smirnov test was performed to test the normality of asthma control scores. Its results revealed the normal distribution of the scores. Subsequently, the repeated-measures analysis of variance, the independent-sample t, and Bonferroni’s post hoc tests were used to analyze the data at a significance level of less than 0.05.
3.1. Ethical Considerations
The ethical approval and necessary permissions for the study were obtained from Birjand University of Medical Sciences, Birjand, Iran (approval code: IR.BUMS.REC.1395.179). Moreover, arrangements for the study were made with the authorities of the study setting. Participants and their parents were provided with information about the study and the confidential management of the study data. Then, parent informed consent was secured.